Midecamycin

Midecamycin
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J01FA03 (WHO) ;
Identifiers
	IUPAC name (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-4-(dimethylamino)-5-hydroxy-6-{[(4R,6S,7R,9R,10R,11E,13E,16R)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-4-(propanoyloxy)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl propanoate;
CAS Number	35457-80-8 ;
PubChem CID	5382853;
ChemSpider	4445365 ;
UNII	N34Z0Y5UH7;
KEGG	D01339 ;
CompTox Dashboard (EPA)	DTXSID5045463 ;
ECHA InfoCard	100.047.784
Chemical and physical data
Formula	C41H67NO15
Molar mass	813.968 g/mol g·mol−1
3D model (JSmol)	Interactive image;
Melting point	155 to 156 °C (311 to 313 °F)
Solubility in water	Soluble in acidic/low pH water; Very soluble in methanol, chloroform, ethyl acetate, benzene, ethyl ether; Almost completely in ethanol(>95.5) mg/mL (20 °C)
	SMILES O=CC[C@H]3C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@H](OC(=O)C[C@@H](OC(=O)CC)[C@H](OC)[C@H]3O[C@@H]2O[C@@H]([C@@H](O[C@@H]1O[C@H]([C@H](OC(=O)CC)[C@](O)(C1)C)C)[C@H](N(C)C)[C@H]2O)C)C;
	InChI InChI=1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1 ; Key:DMUAPQTXSSNEDD-QALJCMCCSA-N ;
(verify)

Midecamycin is a macrolide antibiotic. Synthesized from Streptomyces mycarofaciens.

Physical Properties

Melting point vary depending on the compound type. It may also vary depending on the source consulted. Example:

For the A₁ type:

The Merck Index reports 155-156 Celsius. The Japanese Pharmacopoeia reports 153–158 Celsius.

For the A₃ type:

The Merck Index reports 122-125 Celsius.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.